Table 3.
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
|
|
|||
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age | - | - | 1.019 (0.988–1.050) | 0.239 |
Sex, male | 1.402 (0.548–3.587) | 0.438 | 2.319 (0.891–6.034) | 0.085 |
Lesion length >8 cm | 2.624 (1.178–4.389) | 0.042 | 2.904 (1.161–5.197) | 0.048 |
TASC II C or D | 2.050 (1.044–3.689) | 0.031 | 3.103 (1.676–5.745) | 0.000 |
Concurrent procedure | 0.894 (0.428–1.945) | 0.614 | 0.938 (0.537–1.865) | 0.752 |
Critical limb ischemia | 1.161 (0.604–2.073) | 0.378 | 1.029 (0.578–1.830) | 0.924 |
Patent tibial artery | - | - | 0.349 (0.125–0.783) | 0.028 |
Hypertension | 1.524 (0.092–1.946) | 0.432 | 0.788 (0.437–1.419) | 0.427 |
Chronic renal failure | 1.723 (0.282–2.912) | 0.329 | 1.129 (0.387–3.209) | 0.459 |
Diabetes | 2.503 (1.256–3.888) | 0.039 | 3.420 (1.428–5.774) | 0.035 |
Smoking | 1.144 (0.618–2.105) | 0.396 | 1.163 (0.620–2.182) | 0.638 |
HR, hazard ratio; CI, confidence interval.